Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 21 Issue: 4, April 2021



The Epigenetic Factors that Drive Cancer Drug Resistance free to download

Volume:21   Issue: 4
Pp: 269-273
Manny D. Bacolod
DOI: 10.2174/156800962104210527150438



Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)

Volume:21   Issue: 4
Pp: 274-282
Yusuke Isshiki and Ari Melnick*
DOI: 10.2174/1568009620666210106122750
Published on: 06 January, 2021




miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance

Volume:21   Issue: 4
Pp: 283-288
Zoran Culig*
DOI: 10.2174/1568009620666210108103134
Published on: 07 January, 2021




Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms

Volume:21   Issue: 4
Pp: 289-305
Kenneth K.W. To* and William C.S. Cho
DOI: 10.2174/1568009621666210203111220
Published on: 02 February, 2021




PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance

Volume:21   Issue: 4
Pp: 306-325
Sarah F. Giardina*, Elena Valdambrini, J. David Warren and Francis Barany
DOI: 10.2174/1568009621666210203110857
Published on: 02 February, 2021




The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance

Volume:21   Issue: 4
Pp: 326-352
Shaun Wood, Amber Willbanks and Jason X. Cheng*
DOI: 10.2174/1568009621666210127092828
Published on: 26 January, 2021




Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators open access plus

Volume:21   Issue: 4
Pp: 353-359
Stefanie Rauscher, Richard Greil and Roland Geisberger*
DOI: 10.2174/1568009620666210108102723
Published on: 07 January, 2021